Dr. Hupfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 Gardenview Road
Ste 100
Encinitas, CA 92024Phone+1 760-479-5370
Education & Training
- University of California Davis HealthFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
- University of California Davis HealthResidency, Internal Medicine, 1996 - 1999
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 1997 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 17 citationsSGLT2 Inhibitor–Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy—A Novel HypothesisSunder Mudaliar, Christopher J. Hupfeld, Daniel L Chao
The Journal of Clinical Endocrinology and Metabolism. 2021-04-23 - 71 citationsG Protein-Coupled Receptor Kinase 2 Mediates Endothelin-1-Induced Insulin Resistance via the Inhibition of Both Gαq/11 and Insulin Receptor Substrate-1 Pathways in 3T3...Isao Usui, Takeshi Imamura, Jennie L. Babendure, Hiroaki Satoh, Juu Chin Lu
Molecular Endocrinology. 2005-11-01 - 18 citationsSodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad.Preethika Ekanayake, Christopher J. Hupfeld, Sunder Mudaliar
Current Diabetes Reports. 2020-11-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: